Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Nature Communications|December 10, 2017
Spatial competition constrains resistance to targeted cancer therapyKatarina Bacevic, Robert Noble, Ahmed Soffar, et al.
Medical Oncology (Northwood, London, England)|May 14, 2017
Significance of blood neutrophil-to-lymphocyte ratio for prognostic stratification of patients with gastroesophageal junction adenocarcinoma in the era of the 8th edition of the American Joint Committee on Cancer (AJCC8) stagingAlicia-Marie Conway, Zena Salih, George Papaxoinis, et al.
Elife|March 23, 2023
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translationJeffrey West, Fred Adler, Jill Gallaher, et al.
Vaccine|May 12, 2026
Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01<sub>E-4</sub> tuberculosis vaccineAlemnew F Dagnew, Robert Noble, Amy Cinar, et al.
Journal of Crohn'S & Colitis|January 28, 2021
Impairment of Tissue-Resident Mesenchymal Stem Cells in Chronic Ulcerative Colitis and Crohn's DiseaseCarl Grim, Robert Noble, Gabriela Uribe, et al.
Frontiers in Nutrition|May 15, 2026
Impact of <i>Bifidobacterium infantis</i> supplementation on growth, health outcomes, and gut microbiome features in underweight infants from PakistanJanie Parrino, Justine Sunshine, Kenneth Tripp, et al.
Vaccine|November 2, 2025
Development and qualification of a multiplexed immunoassay to assess the immunogenicity of Shigella vaccinesPaul W Rhyne, Justine Sunshine, Wayne Hogrefe, et al.
Biochemistry|July 9, 2003
Functional and spectroscopic characterization of half-liganded iron-zinc hybrid hemoglobin: evidence for conformational plasticity within the T stateUri Samuni, Laura Juszczak, David Dantsker, et al.
Pediatric Blood & Cancer|November 3, 2016
A phase IIa study of afuresertib, an oral pan-AKT inhibitor, in patients with Langerhans cell histiocytosisRobert J Arceci, Carl E Allen, Ira J Dunkel, et al.
NPJ Precision Oncology|June 3, 2026
When effective anticancer therapies are, in fact, destabilizing the tumor's Group Phenotypic CompositionFrédéric Thomas, Antoine M Dujon, Andriy Marusyk, et al.
Pageof 5